Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.
McCarthy NE, Hedin CR, Sanders TJ, Amon P, Hoti I, Ayada I, Baji V, Giles EM, Wildemann M, Bashir Z, Whelan K, Sanderson I, Lindsay JO, Stagg AJ.
McCarthy NE, et al. Among authors: giles em.
J Clin Invest. 2015 Aug 3;125(8):3215-25. doi: 10.1172/JCI80840. Epub 2015 Jul 13.
J Clin Invest. 2015.
PMID: 26168223
Free PMC article.
Clinical Trial.